DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Enhancing Taxotere [ASCENT-2])

Clinical trial NCT00273338 · TERMINATED

Trial details

NCT number: NCT00273338
Sponsor: Novacea
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2006-01-01
Enrollment: 1200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.